CARLSBAD, Calif., May 9, 2023
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today
announced that management will participate in fireside chats at the
following investor conferences:
- RBC Capital Markets Global Healthcare Conference on
Tuesday, May 16, 2023
- Goldman Sachs 44th Annual Global Healthcare
Conference on Monday, June 12,
2023
A live webcast of the presentations can be accessed on the
Investors & Media section of the Ionis website at
www.ionispharma.com. The replay will be available on the Ionis
website within 48 hours and will be archived for a limited
time.
About Ionis Pharmaceuticals
For more than 30 years, Ionis has been a leader in RNA-targeted
therapy, pioneering new markets and changing standards of care.
Ionis currently has four marketed medicines and a promising
late-stage pipeline highlighted by cardiovascular and neurological
franchises. Our scientific innovation began and continues with the
knowledge that sick people depend on us, which fuels our vision to
become the leader in genetic medicine, utilizing a multi-platform
approach to discover, develop and deliver life-transforming
therapies.
To learn more about Ionis visit www.ionispharma.com or follow us
on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301818787.html
SOURCE Ionis Pharmaceuticals, Inc.